References
- Horwitz BJ, Fisher RS. The irritable bowel syndrome. N. Engl. J. Med.344(24), 1846–1850 (2001).
- Paré P, Gray J, Lam S et al. Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study. Clin. Ther.28(10), 1726–1735 (2006).
- Manning AP, Thompson WG, Heaton KW, Morris AF. Towards positive diagnosis of the irritable bowel. Br. Med. J.2(6138), 653–654 (1978).
- Drossman DA. The functional gastrointestinal disorders and the Rome II process. Gut45(Suppl. 2), II1–II5 (1999).
- Mostafa R. Rome III: The functional gastrointestinal disorders, third edition, 2006. World J. Gastroenterol.14(13), 2124–2125 (2008).
- McKendrick MW, Read NW. Irritable bowel syndrome – post salmonella infection. J. Infection29(1), 1–3 (1994).
- Jakate S, Demeo M, John R, Tobin M, Keshavarzian A. Mastocytic enterocolitis: increased mucosal mast cells in chronic intractable diarrhea. Arch. Pathol. Lab. Med.130(3), 362–367 (2006).
- Tobin MC, Moparty B, Farhadi A, DeMeo MT, Bansal PJ, Keshavarzian A. Atopic irritable bowel syndrome: a novel subgroup of irritable bowel syndrome with allergic manifestations. Ann. Allergy Asthma Immunol.100(1), 49–53 (2008).
- Farhadi A, Fields JZ, Keshavarzian A. Mucosal mast cells are pivotal elements in inflammatory bowel disease that connect the dots: stress, intestinal hyperpermeability and inflammation. World J. Gastroenterol.13(22), 3027–3030 (2007).
- Broide DH. Molecular and cellular mechanisms of allergic disease. J. Allergy Clin. Immunol.108(2 Suppl.), S65–S71 (2001).
- Magnusson J, Lin XP, Dahlman-Höglund A et al. Seasonal intestinal inflammation in patients with birch pollen allergy. J. Allergy Clin. Immunol.112(1), 45–50 (2003).
- Sloane D, Sheffer A. Oral allergy syndrome. Allergy Asthma Proc.22(5), 321–325 (2001).
- Sampson HA. Food allergy. Part 1: immunopathogenesis and clinical disorders. J. Allergy Clin. Immunol.103(5 Pt 1), 717–728 (1999).
- Atkinson W, Sheldon TA, Shaath N, Whorwell PJ. Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut53(10), 1459–1464 (2004).
- Zar S, Benson MJ, Kumar D. Food-specific serum IgG4 and IgE titers to common food antigens in irritable bowel syndrome. Am. J. Gastroenterol.100(7), 1550–1557 (2005).
- Zuo XL, Li YQ, Li WJ et al. Alterations of food antigen-specific serum immunoglobulins G and E antibodies in patients with irritable bowel syndrome and functional dyspepsia. Clin. Exp. Allergy37(6), 823–830 (2007).
- Zar S, Mincher L, Benson MJ, Kumar D. Food-specific IgG4 antibody-guided exclusion diet improves symptoms and rectal compliance in irritable bowel syndrome. Scand. J. Gastroenterol.40(7), 800–807 (2005).
- Karulin AY, Hesse MD, Yip HC, Lehmann PV. Indirect IL-4 pathway in type 1 immunity. J. Immunol.168(2), 545–553 (2002).
- Isolauri E, Arvola T, Sütas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin. Experiment. Allergy30(11), 1604–1610 (2000).
- O’Mahony L, McCarthy J, Kelly P et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology128, 541–551 (2005).
- Breiteneder H, Ebner C. Molecular and biochemical classification of plant-derived food allergens. J. Allergy Clin. Immunol.106(1 Pt 1), 27–36 (2000).
Websites
- The Allergy Report. American Academy of Allergy, Asthma, and Immunology. Milwaukee, WI, USA, 1996–2005. www.aaaai.org